AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34085472 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture combined with row‐like puncture at sternocleidomastoid
Number of subjects: 60
Study 34085472 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study 34843355 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy (PE)
Number of subjects: 86
Study 34843355 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Therapy (RT)
Number of subjects: 86
Study 35853676 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational counselling and text message reminders
Number of subjects: 150
Study 36606011 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 70
Study 36606011 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 70
Study 32085633 — intervention group
Group type: EXPERIMENTAL
Intervention: Birch pollen immunotherapy
Number of subjects: 8
Study 34966141 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin at 10 mg/kg/d
Number of subjects: 0
Study 34966141 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline at 4.4 mg/kg/d for 5 days
Number of subjects: 0
Study 34966141 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study 34966141 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 0
Study 35732989 — intervention group
Group type: EXPERIMENTAL
Intervention: hBO‐HD (640 mg)
Number of subjects: 223
Study 35732989 — intervention group
Group type: EXPERIMENTAL
Intervention: hBO‐MD (320 mg)
Number of subjects: 223
Study 35732989 — intervention group
Group type: EXPERIMENTAL
Intervention: hBO‐LD (160 mg)
Number of subjects: 223
Study 35732989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 33772435 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted MREAL curriculum
Number of subjects: 5523
Study 33772435 — intervention group
Group type: COMPARATOR
Intervention: Original kiREAL curriculum (translated into Spanish)
Number of subjects: 5523
Study 33772435 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 5523
Study 32594789 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training plus moderate-to-vigorous intensity exercise
Number of subjects: 585
Study 32594789 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise alone
Number of subjects: 585
Study 32594789 — intervention group
Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 585
Study 35270582 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT) for 10 weeks
Number of subjects: 60
Study 35270582 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced PFMT using EMG biofeedback for 10 weeks
Number of subjects: 60
Study 34765004 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity group (HSG) - acupressure at five acupoints with highest sensitivity to pain
Number of subjects: 202
Study 34765004 — intervention group
Group type: COMPARATOR
Intervention: Low-sensitivity group (LSG) - acupressure at five acupoints with lowest sensitivity to pain
Number of subjects: 202
Study 34765004 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity group (HSG)
Number of subjects: 202
Study 33031293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 100
Study 33031293 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound therapy
Number of subjects: 100
Study 36239756 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy with once-weekly subcutaneous injection of teriparatide 56.5 μg for 72 weeks, followed by alendronate for 48 weeks
Number of subjects: 505
Study 36239756 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with alendronate for 120 weeks
Number of subjects: 505
Study 32789966 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltitrexed (RTX) 2 mg/m2 every 2 weeks
Number of subjects: 0
Study 32789966 — intervention group
Group type: COMPARATOR
Intervention: Raltitrexed (RTX) 3 mg/m2 every 3 weeks
Number of subjects: 0
Study 32511687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (600 mg by intravenous infusion every 24 weeks)
Number of subjects: 1656
Study 32511687 — intervention group
Group type: COMPARATOR
Intervention: Interferon β‐1a (44 μg subcutaneously 3 times a week)
Number of subjects: 1656
Study 32511687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 1656
Study 32511687 — intervention group
Group type: COMPARATOR
Intervention: Interferon β‐1a
Number of subjects: 1656
Study 35248721 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 56
Study 35248721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 35045390 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for younger patients
Number of subjects: 356
Study 35045390 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for older patients
Number of subjects: 356
Study 35045390 — intervention group
Group type: COMPARATOR
Intervention: No-age control group
Number of subjects: 356
Study 33599430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary habits assessment of male adolescents with type 1 diabetes
Number of subjects: 20
Study 32152817 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based education (GE)
Number of subjects: 105
Study 32152817 — intervention group
Group type: EXPERIMENTAL
Intervention: Social network-based education (SNE)
Number of subjects: 105
Study 32152817 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine lymphedema treatments)
Number of subjects: 105
Study 35512728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 14221
Study 35512728 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14221
Study 35512728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (ventilated patients)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: COMPARATOR
Intervention: Control (ventilated patients)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (not ventilated but on oxygen)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: COMPARATOR
Intervention: Control (not ventilated but on oxygen)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (not on oxygen initially)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: COMPARATOR
Intervention: Control (not on oxygen initially)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (all not ventilated initially)
Number of subjects: 14221
Study 35512728 — intervention group
Group type: COMPARATOR
Intervention: Control (all not ventilated initially)
Number of subjects: 14221
Study 33858397 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (measured in MET∙h/day)
Number of subjects: 330
Study 33858397 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin concentration (g/dL)
Number of subjects: 330
Study 33858397 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 330
Study 33858397 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI: kg/m2)
Number of subjects: 330
Study 33858397 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational attainment
Number of subjects: 330
Study 36476247 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual intervention
Number of subjects: 120
Study 36476247 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention
Number of subjects: 120
Study 36476247 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 120
Study 33428786 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin (460 mg/m2) and docetaxel (in escalating doses) after preoperative systemic chemotherapy and surgical procedure.
Number of subjects: 25
Study 34269818 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab/lenalidomide/dexamethasone (D‐Rd)
Number of subjects: 718
Study 34269818 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab/bortezomib/melphalan/prednisone (D‐VMP)
Number of subjects: 718
Study 33155417 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment (specific drug not mentioned)
Number of subjects: 0
Study 33155417 — intervention group
Group type: COMPARATOR
Intervention: Censoring at initiation of subsequent therapy
Number of subjects: 0
Study 33155417 — intervention group
Group type: EXPERIMENTAL
Intervention: Considering recurrence or progression events (including death) before and after initiation of subsequent therapy
Number of subjects: 0
Study 33155417 — intervention group
Group type: EXPERIMENTAL
Intervention: Considering the start of subsequent therapy as an event
Number of subjects: 0
Study 35762832 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-facing intervention using electronic health record functionalities (EHR)
Number of subjects: 1825
Study 35762832 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure messaging to eligible patients
Number of subjects: 1825
Study 35762832 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 1825
Study 34341153 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (incoBoNT/A)
Number of subjects: 255
Study 34341153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 32618265 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass Drug Administration (MDA) with dihydroartemisinin‐piperaquine (DHAP)
Number of subjects: 60
Study 32618265 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal MDA with DHAP at the household level
Number of subjects: 60
Study 32618265 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard of care
Number of subjects: 60
Study 35108380 — intervention group
Group type: EXPERIMENTAL
Intervention: MDHAQ
Number of subjects: 13391
Study 34274304 — intervention group
Group type: EXPERIMENTAL
Intervention: No intake of ASBs (intervention group)
Number of subjects: 45
Study 34274304 — intervention group
Group type: COMPARATOR
Intervention: Regular intake of ASBs (control group)
Number of subjects: 45
Study 35322232 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab plus chemotherapy
Number of subjects: 0
Study 35322232 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study 35322232 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy alone
Number of subjects: 0
Study 33176712 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred care
Number of subjects: 4831
Study 33340154 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical grade honey gel (L-Mesitran Soft®) applied intraoperatively on the linea alba
Number of subjects: 89
Study 33340154 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medical grade honey gel)
Number of subjects: 89
Study 33340154 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical grade honey gel (L-Mesitran Soft®)
Number of subjects: 89
Study 33340154 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors associated with infection
Number of subjects: 89
Study 35792299 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective Control Training (AffeCT)
Number of subjects: 48
Study 35792299 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 48
Study 34547261 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg tablet dissolved in apple juice)
Number of subjects: 60
Study 34547261 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 mL of apple juice)
Number of subjects: 60
Study 34547261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33849611 — intervention group
Group type: EXPERIMENTAL
Intervention: InterFACE mHealth tool
Number of subjects: 48
Study 33849611 — intervention group
Group type: COMPARATOR
Intervention: Conventional communication methods
Number of subjects: 48
Study 32495671 — intervention group
Group type: EXPERIMENTAL
Intervention: Position management, manual rotation of fetal position, use of a U‐shaped birth stool
Number of subjects: 384
Study 32495671 — intervention group
Group type: COMPARATOR
Intervention: Control group (position selected by women and routine nursing)
Number of subjects: 384
Study 34614288 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene block (Group-IB, n=20)
Number of subjects: 42
Study 34614288 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (Group-GA, n=22)
Number of subjects: 42
Study 34474682 — intervention group
Group type: EXPERIMENTAL
Intervention: Care manager model
Number of subjects: 9
Study 32028255 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural turf
Number of subjects: 15
Study 32028255 — intervention group
Group type: EXPERIMENTAL
Intervention: Astroturf
Number of subjects: 15
Study 32028255 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation artificial turf
Number of subjects: 15
Study 32028255 — intervention group
Group type: EXPERIMENTAL
Intervention: GPS location at C7
Number of subjects: 15
Study 32028255 — intervention group
Group type: EXPERIMENTAL
Intervention: GPS location at mid-tibia
Number of subjects: 15
Study 34301217 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-mixed GIC (Fuji IX®, GC Europe)
Number of subjects: 145
Study 34301217 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated GIC (Equia Fill®, GC Europe)
Number of subjects: 145
Study 34301217 — intervention group
Group type: COMPARATOR
Intervention: Occlusoproximal restorations
Number of subjects: 145
Study 32783178 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy
Number of subjects: 756
Study 32783178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study 32783178 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib
Number of subjects: 756
Study 35831719 — intervention group
Group type: EXPERIMENTAL
Intervention: FACT intervention (web-based psychosocial intervention)
Number of subjects: 46
Study 33388991 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 58
Study 33388991 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbinate outfracture in combination with radiofrequency ablation
Number of subjects: 58
Study 36332826 — intervention group
Group type: EXPERIMENTAL
Intervention: PelviSense-assisted PFMT
Number of subjects: 51
Study 36332826 — intervention group
Group type: EXPERIMENTAL
Intervention: CB-assisted PFMT
Number of subjects: 51
Study 36332826 — intervention group
Group type: COMPARATOR
Intervention: PFMT alone
Number of subjects: 51
Study 32446245 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (0.17 mg/kg)
Number of subjects: 0
Study 32446245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35949295 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 308
Study 35949295 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 308
Study 33127858 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured waist-to-hip ratio increase of 0.06
Number of subjects: 281228
Study 33127858 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured BMI increase of 5-kg/m2
Number of subjects: 281228
Study 33127858 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted waist-to-hip ratio increase of 0.06
Number of subjects: 281228
Study 33127858 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted BMI increase of 5-kg/m2
Number of subjects: 281228
Study 33127858 — intervention group
Group type: COMPARATOR
Intervention: Adjustment for diabetes and measured BP
Number of subjects: 281228
Study 33127858 — intervention group
Group type: COMPARATOR
Intervention: Mediator adjustment using multivariable MR for genetically-predicted waist-to-hip ratio
Number of subjects: 281228
Study 33127858 — intervention group
Group type: COMPARATOR
Intervention: Mediator adjustment using multivariable MR for genetically-predicted BMI
Number of subjects: 281228
Study 32314026 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN segmentation
Number of subjects: 40
Study 32314026 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted segmentations
Number of subjects: 40
Study 32314026 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN segmentations
Number of subjects: 40
Study 32314026 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN model
Number of subjects: 40
Study 33000985 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief anti-ageism messages addressing views of aging
Number of subjects: 349
Study 33000985 — intervention group
Group type: COMPARATOR
Intervention: Control group (no message)
Number of subjects: 349
Study 32727703 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-to-palate resistance training (TPRT) for 8 weeks (5 days per week)
Number of subjects: 91
Study 32727703 — intervention group
Group type: COMPARATOR
Intervention: Usual daily activities (Control group)
Number of subjects: 91
Study 34656996 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatically titrating O2-system (ATOS) targeting SpO2 of 92%
Number of subjects: 50
Study 34656996 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatically titrating O2-system (ATOS)
Number of subjects: 50
Study 34656996 — intervention group
Group type: COMPARATOR
Intervention: Exercise titrated constant flow oxygen system (CFOS)
Number of subjects: 50
Study 33566351 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instructions
Number of subjects: 0
Study 33566351 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face instructions
Number of subjects: 0
Study 32701929 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte‐ and platelet‐rich fibrin (L‐PRF) used to fill and cover extraction sockets (n=11, Test Group)
Number of subjects: 23
Study 32701929 — intervention group
Group type: COMPARATOR
Intervention: No L‐PRF used (n=12, Control Group)
Number of subjects: 23
Study 36127447 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory level electrical stimulation
Number of subjects: 31
Study 36127447 — intervention group
Group type: COMPARATOR
Intervention: Motor level electrical stimulation
Number of subjects: 31
Study 36127447 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (Sensory and Motor)
Number of subjects: 31
Study 35590052 — intervention group
Group type: EXPERIMENTAL
Intervention: Draughts Comic Strip
Number of subjects: 0
Study 35590052 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap Opera Comic Strip
Number of subjects: 0
Study 36046939 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person lifestyle intervention (LI)
Number of subjects: 211
Study 36046939 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone conference call lifestyle intervention (LI)
Number of subjects: 211
Study 36046939 — intervention group
Group type: COMPARATOR
Intervention: Medical nutrition therapy (MNT)
Number of subjects: 211
Study 36046939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LI) arms
Number of subjects: 211
Study 33510421 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antenatal counseling of prematurity
Number of subjects: 76
Study 33510421 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling by MFM providers
Number of subjects: 76
Study 34914682 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART educational intervention (four learning modules on goal setting and coaching)
Number of subjects: 68
Study 34914682 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART educational intervention
Number of subjects: 68
Study 34914682 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study 33059008 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Nannochloropsis oculata
Number of subjects: 4
Study 33059008 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Nannochloropsis oculata
Number of subjects: 4
Study 33059008 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% Nannochloropsis oculata
Number of subjects: 4
Study 33059008 — intervention group
Group type: COMPARATOR
Intervention: Control (0% Nannochloropsis oculata)
Number of subjects: 4
Study 35708992 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution‐Focused Group Psychoeducation
Number of subjects: 39
Study 35708992 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 32946618 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 1004
Study 33728707 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk fill composite resin (BF)
Number of subjects: 91
Study 33728707 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 91
Study 34443998 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) application
Number of subjects: 90
Study 34443998 — intervention group
Group type: COMPARATOR
Intervention: Control (no PRF application)
Number of subjects: 90
Study 32665432 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 171
Study 36472969 — intervention group
Group type: EXPERIMENTAL
Intervention: ZingiVir-H
Number of subjects: 116
Study 36472969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 34228172 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported symptoms after treatment
Number of subjects: 579
Study 32278781 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of immediate-release venlafaxine
Number of subjects: 20
Study 32278781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34460029 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 22
Study 34138909 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 convalescent plasma (CCP) collection and processing
Number of subjects: 192
Study 34138909 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for transfusion transmissible infections (TTIs)
Number of subjects: 192
Study 34138909 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody titer testing
Number of subjects: 192
Study 36029336 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuro (group A)
Number of subjects: 60